RG
Redmile Group Portfolio holdings
AUM
$940M
This Quarter Return
-13.65%
1 Year Return
+75.78%
3 Year Return
+543.67%
5 Year Return
+585.96%
10 Year Return
+6,653.82%
AUM
$2.62B
AUM Growth
+$2.62B
(-18%)
Cap. Flow
+$147M
Cap. Flow
% of AUM
5.6%
Top 10 Holdings %
Top 10 Hldgs %
51.83%
Holding
74
New
4
Increased
19
Reduced
26
Closed
3
Top Buys
Top Sells
| 1 |
argenx
ARGX
|
$49.3M |
| 2 |
UnitedHealth
UNH
|
$27.3M |
| 3 |
LivaNova
LIVN
|
$21.7M |
| 4 |
ICU Medical
ICUI
|
$21.6M |
| 5 |
SLGC
SomaLogic, Inc. Class A Common Stock
SLGC
|
$8.22M |
Sector Composition
| 1 | Healthcare | 96.11% |
| 2 | Consumer Staples | 2.55% |
| 3 | Industrials | 0.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
VERV
26
DELISTED
Verve Therapeutics
VERV
| $28M | 1.07% |
1,833,547
-1,781
| -0.1% | -$27.2K |
|
27
Absci
ABSI
$356M
| $26.7M | 1.02% |
8,031,094
| – | – |
|
28
Stoke Therapeutics
STOK
$1.08B
| $26.3M | 1.01% |
1,993,268
-31,100
| -2% | -$411K |
|
|
AUGX
29
DELISTED
Augmedix, Inc. Common Stock
AUGX
| $25.9M | 0.99% |
14,380,327
| – | – |
|
30
BioMarin Pharmaceuticals
BMRN
$11.3B
| $24.9M | 0.95% |
+300,000
| New | +$24.9M |
|
31
Pliant Therapeutics
PLRX
$105M
| $24.6M | 0.94% |
3,069,001
-11,800
| -0.4% | -$94.5K |
|
32
Entrada Therapeutics
TRDA
$202M
| $23.8M | 0.91% |
1,954,419
| – | – |
|
33
Shattuck Labs
STTK
$61.3M
| $22.8M | 0.87% |
5,619,914
| – | – |
|
|
OSH
34
DELISTED
Oak Street Health, Inc.
OSH
| $22.7M | 0.87% |
1,383,619
+180,000
| +15% | +$2.96M |
|
35
Zymeworks
ZYME
$1.07B
| $20.3M | 0.78% |
3,835,818
+1,721,621
| +81% | +$9.12M |
|
36
Prothena Corp
PRTA
$452M
| $20M | 0.76% |
736,175
| – | – |
|
|
DCPH
37
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $18.8M | 0.72% |
1,430,917
+766,100
| +115% | +$10.1M |
|
38
Scholar Rock
SRRK
$3.3B
| $18.7M | 0.71% |
3,403,926
+996,600
| +41% | +$5.47M |
|
|
NVRO
39
DELISTED
NEVRO CORP.
NVRO
| $17.8M | 0.68% |
405,517
-5,500
| -1% | -$241K |
|
40
Stevanato
STVN
$6.36B
| $17.6M | 0.67% |
1,115,825
-34,400
| -3% | -$544K |
|
|
GRTS
41
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $16.8M | 0.64% |
6,952,760
+81,022
| +1% | +$196K |
|
42
Akero Therapeutics
AKRO
$3.65B
| $15M | 0.57% |
1,587,285
-15,000
| -0.9% | -$142K |
|
43
RAPT Therapeutics
RAPT
$187M
| $14.9M | 0.57% |
817,832
+69,155
| +9% | +$1.26M |
|
|
ISEE
44
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $14.6M | 0.56% |
1,518,900
+33,100
| +2% | +$318K |
|
45
Jazz Pharmaceuticals
JAZZ
$7.99B
| $14.6M | 0.56% |
93,264
-21,500
| -19% | -$3.35M |
|
46
Annexon
ANNX
$225M
| $13.2M | 0.5% |
3,503,190
+300,273
| +9% | +$1.13M |
|
47
Nuvation Bio
NUVB
$1.08B
| $11.2M | 0.43% |
3,471,709
| – | – |
|
48
Tandem Diabetes Care
TNDM
$834M
| $11.1M | 0.42% |
187,460
-83,758
| -31% | -$4.96M |
|
|
SLGC
49
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
| $9.44M | 0.36% |
2,088,639
-1,818,131
| -47% | -$8.22M |
|
|
NVTA
50
DELISTED
Invitae Corporation
NVTA
| $9.29M | 0.35% |
3,805,403
| – | – |
|